BACKGROUND: Little is known about the clinical outcomes of acute myocardial infarction (AMI) in patients with a history of malignant tumor (MT). PATIENTS AND METHODS: We retrospectively studied 1,295 consecutive patients with AMI who underwent primary percutaneous coronary intervention within 24 hours of onset. The patients were divided into two groups: those with a history of MT (MT group, n=50) and those without (non-MT group, n=1,245). RESULTS: The MT group was older, and had lower hemoglobin, total protein, and albumin levels. All-cause mortality and re-admission rates due to acute decompensated heart failure (ADHF) were significantly higher in the MT group. Multivariate analysis showed that a history of MT was an independent predictor for all-cause mortality and re-admission due to ADHF. CONCLUSION: The clinical outcomes of patients with AMI with a history of MT are poor, and a history of MT is an independent predictor for all-cause mortality and re-admission due to ADHF. These patients may need careful risk management for heart failure to avoid re-admissions due to ADHF. Copyright
BACKGROUND: Little is known about the clinical outcomes of acute myocardial infarction (AMI) in patients with a history of malignant tumor (MT). PATIENTS AND METHODS: We retrospectively studied 1,295 consecutive patients with AMI who underwent primary percutaneous coronary intervention within 24 hours of onset. The patients were divided into two groups: those with a history of MT (MT group, n=50) and those without (non-MT group, n=1,245). RESULTS: The MT group was older, and had lower hemoglobin, total protein, and albumin levels. All-cause mortality and re-admission rates due to acute decompensated heart failure (ADHF) were significantly higher in the MT group. Multivariate analysis showed that a history of MT was an independent predictor for all-cause mortality and re-admission due to ADHF. CONCLUSION: The clinical outcomes of patients with AMI with a history of MT are poor, and a history of MT is an independent predictor for all-cause mortality and re-admission due to ADHF. These patients may need careful risk management for heart failure to avoid re-admissions due to ADHF. Copyright
Authors: Stuart B Prenner; Anupam Kumar; Lei Zhao; Mary E Cvijic; Michael Basso; Thomas Spires; Zhuyin Li; Melissa Yarde; Priyanka Bhattacharya; Payman Zamani; Jeremy Mazurek; Zhaoqing Wang; Dietmar Seiffert; David A Gordon; Julio A Chirinos Journal: Am J Cardiol Date: 2019-11-19 Impact factor: 2.778
Authors: C P Cannon; C M Gibson; C T Lambrew; D A Shoultz; D Levy; W J French; J M Gore; W D Weaver; W J Rogers; A J Tiefenbrunn Journal: JAMA Date: 2000-06-14 Impact factor: 56.272
Authors: Mathias Rauchhaus; Andrew L Clark; Wolfram Doehner; Constantinos Davos; Aidan Bolger; Rakesh Sharma; Andrew J S Coats; Stefan D Anker Journal: J Am Coll Cardiol Date: 2003-12-03 Impact factor: 24.094
Authors: Giuseppe De Luca; Harry Suryapranata; Felix Zijlstra; Arnoud W J van 't Hof; Jan C A Hoorntje; A T Marcel Gosselink; Jan Henk Dambrink; Menko Jan de Boer Journal: J Am Coll Cardiol Date: 2003-09-17 Impact factor: 24.094